NCCN Guidelines® Insights - Management of Immunotherapy-Related Toxicities, Version 1.2020 |
1.00 |
03/10/2020 - 12:00am to 03/10/2021 - 12:00am |
Recorded Presentations from the NCCN 2020 Congress Series: Breast Cancer |
|
03/13/2020 - 12:00am to 03/15/2021 - 12:00am |
Genetics/Familial Risk Assessment for Breast Cancer: Controversies and Evolving Principles |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Adjuvant and Neoadjuvant Therapies for Early Stage Breast Cancer, Including SABCS Updates |
1.00 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Surgical Management of Breast Cancer, Including SABCS Updates |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Is There a Role for Proton Therapy in the Treatment of Breast Cancer? |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Principles of Breast Reconstruction after Surgery |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Management of Rare Breast Cancers |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Biomarker Assays for Treatment Selection of Advanced Breast Cancer |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Management of Metastatic Breast Cancer, Including SABCS Updates |
0.75 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Management of Toxicities with Targeted Therapies for Breast Cancer |
0.25 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Practical Application of Immuno-Oncology in Renal Cell Carcinoma |
1.75 |
03/17/2020 - 12:00am to 03/17/2021 - 12:00am |
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer |
1.00 |
03/18/2020 - 12:00am to 03/18/2021 - 12:00am |
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma |
0.75 |
03/18/2020 - 12:00am to 03/18/2021 - 12:00am |
BCOP Test - Current Therapy Options for Graft-Versus-Host Disease |
|
04/01/2020 - 2:00pm to 04/01/2021 - 12:00am |